Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.
Efpeglenatide, a new GLP-1 receptor agonist, referenced to liraglutide in Phase II trial.
Read More »EXCEED Trial: Efpeglenatide Displays Significant Reduction in HbA1c and Body Weight
Preventing Diabetes with Resistance Training or Aerobic Exercise
Can resistance training improve beta-cell function in patients with prediabetes?
Read More »Medications That Can Reduce The Conversion To Type 2 Diabetes
Pharmacological interventions may have a role to play in preventing progression to type 2 diabetes, but are they more important than lifestyle factors?
Read More »Sugar Substitutes and Type 2 Diabetes
A new study looks at the growing use of non-nutritive sweeteners and if they may cause, or help prevent, type 2 diabetes.
Read More »Coronary Artery Calcification and Cardiovascular Disease in Patients with Type 1 Diabetes
Is the CAC score a reliable tool in assessing cardio risk in patients with type 1 diabetes?
Read More »An Overview of Double Diabetes (DD)
What do we know today about patients who have double diabetes?
Read More »Depression + Diabetes = Increased Risk for Cardiovascular Outcomes
Patients who have diabetes should be screened for psychological risk factors.
Read More »Nutritional Approach in Management of Diabetes or Prediabetes
How effective is medical nutrition therapy in improving diabetes and prediabetes outcomes?
Read More »Improving Glycemic Control in T1DM Can Decrease Risk of Fracture
Having diabetes increases patients’ risk for fracture six-fold in T1DM and three-fold in T2DM.
Read More »Who, and When, Should We Screen for Metabolic Risk?
Updated guidelines on how best to screen for metabolic risk to help with the prevention of both type 2 diabetes and ASCVD.
Read More »